期刊文献+

肾移植前巨细胞病毒感染状况及其对术后的影响 被引量:2

Active cytomegalovirus infection before renal transplantation and its effect on the patients
下载PDF
导出
摘要 目的明确肾移植前尿毒症患者活动性巨细胞病毒(CMV)感染的发生状况及其对术后的影响.方法自2002年6月~2003年9月,使用荧光素标记的抗CMV-pp65单克隆抗体,检测176例肾移植患者术前外周血CMV-pp65抗原血症;肾移植后每2~4周复查1次,共为期6个月;分析术前CMV-pp65抗原血症状况对术后患者CMV-pp65抗原血症强度和CMV病发生率的影响;另于同期内检测26例健康成人CMV-pp65抗原血症做相关对照.结果 26例健康成人CMV-pp65抗原血症均为(-);肾移植前有11.4%(20/176)的尿毒症患者CMV-pp65抗原血症为(+);这类患者肾移植后发生高活动性CMV感染(即CMV-pp65抗原血症指数>100)和CMV病的发生率均明显高于移植前CMV-pp65抗原血症为(-)的患者.结论肾移植前活动性CMV感染高达11.4%;术前活动性CMV感染是导致肾移植后发生高活动性CMV感染和CMV病的重要原因. Objective To discover the matter of active cytomegalovirus (CMV) infection before renal transplantation and its effect on the patients after transplantation.Methods The numbers of pp65 positive cells in peripheral blood in 26 normal persons who were used as control and 176 uremia patients before renal transplantation were determined between June 1, 2002 and September 30, 2003. The variations of number of pp65 positive cells in peripheral blood in patients after renal transplantation were investgated.Results In control group the number of pp65 positive cells in peripheral blood was 0 /5×10 4 WBC. Before renal transplantation there was 11.4 percent of uremia patients whose pp65 positive cell counting was more than 0 cell /5×10 4 WBC.In this kind of patient the case number of serious active CMV infection(pp65 positive cell counting was more than 100 cells /5×10 4 WBC) and CMV disease after renal transplantation was more than others . The difference was significant.Conclusions The findings suggest that active CMV infection before renal transplantation is an important sake that causes serious active CMV infection and even CMV disease after renal transplantation.
出处 《重庆医学》 CAS CSCD 2005年第3期364-366,368,共4页 Chongqing medicine
关键词 移植 巨细胞病毒 kidney transplantation cytomegalovirus
  • 相关文献

参考文献13

  • 1Durlik M, Siennicka J, Litwinska B,et al. Comparison of antigenemia (pp65) assay and polymerase chain reaction in diagnosis of cytomegalovirus infection in renal transplant recipients treated with ATG[J]. Transplant Proc,2000,32: 1350.
  • 2Piiparinen H, Hckerstedt K, Gronhagen C.et al.Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV Monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients[J].J Clin Virol,2004, 30:258.
  • 3Inkinen K, Soots A, Krogerus L, et al. Cytomegalovirus increases collagen synthesis in chronic rejection in the rat[J]. Nephrol Dial Transplant,2002,17 : 772.
  • 4Anglicheau D,Lautrette A, Scieux C,et al. Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis[J]. Transplant Proc,2002,34:2826.
  • 5Kuypers DR,Evenepoel P, Maes BD,et al.Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients[J]. Transplant Proc,2002,34:1164.
  • 6赵树铭,成晓玲,李书武,刁荣华,刘璐,张红,陈寒梅,陈敏.冰冻和常规保存机采血小板在血液病患者中的应用评价[J].重庆医学,2003,32(3):289-290. 被引量:19
  • 7Lee W, Tsang WK, Tong KL,et al. Cytomegalovirus infection and graft rejection in renal transplantation: a single-center experience[J]. Transplant Proc,2003,35: 282.
  • 8Maar EF,Verschuuren EA,Harmsen MC, et al.Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients[J]. Transplant Infect Dis, 2003,5: 112.
  • 9Vazquez MA.Chronic rejection of renal transplants: new clinical insights[J]. Am J Med Sci,2000,320: 43.
  • 10Kloover JS, Soots AP, Krogerus LA, et al. Rat cytomegalovirus infection in kidney allograft recipients is associated with increased expression of intracellular adhesion molecule-1 vascular adhesion molecule-1, and their ligands leukocyte function antigen-1 and very late antigen-4 in the graft[J]. Transplantation,2000,69: 2641.

二级参考文献6

共引文献19

同被引文献11

  • 1王平贤,王安静,黄赤兵,范明齐,张艮甫.洛沙坦预防慢性移植物肾病[J].重庆医学,2005,34(2):238-239. 被引量:3
  • 2陈江华,茅幼英,何强,吴建永,吕蓉.术前巨细胞病毒感染对移植肾急性排斥的影响[J].中华肾脏病杂志,2005,21(4):223-226. 被引量:9
  • 3Houlihan CA,Akdeniz A,Tsalamandris C,et al.Urinary transforming growth factor-beta excretion in patients with hypertension,type 2 diabetes,and elevated albumin excretion rate:effects of angiotensin receptor blockade and sodium restriction[J].Diabetes Care,2002,25(6):1072
  • 4Rogier E,Durrbach A,Abecassis L,et al.A novel biological assay to detect the active form of TGF-beta in urine to monitor renal allograft rejection[J].Kidney Int,2005,68(4):1875
  • 5Scolari MP,Cappuccilli ML,Lanci N,et al.Predictive factors in chronic allograft nephropathy[J].Transplant Proc,2005,37(6):2482
  • 6Vallejos A,Alperovich G,Moreso F,et al.Resistive index and chronic allograft nephropathy evaluated in protocol biopsies as predictors of graft outcome[J].Nephrol Diag Transplant,2005,20(11):2511
  • 7Abdel WN,Weston BS,Roberts T,et al.Connective tissue growth factor and regulation of the mesangial cell cycle:role in cellular hypertrophy[J].J Am Soc Nephrol,2002,13(10):2437
  • 8Paul LC.Chronic allograft nephropathy:an update[J].Kidney Int,1999,56(3):783
  • 9Densem CG,Mutlak SM,Pravica V,et al.A novel polymorphism of the gene encoding furin,a TGF-β1 activator,and the influence on cardiac allograft vasculopathy formation[J].Transplant Immunol,2004,37(7):697
  • 10Citterio F,Pozzetto U,Romagnoli J,et al.Plasma levels of transforming growth factor-β1 in renal transplant recipients receiving different immunosuppressive regimens[J].Transplant Proc,2004,36(3):698

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部